Page 81 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Overview of Primary and Secondary Vasculitides 57

[134] Ouyang, R., Mitchell, D. M., Rozdilsky, B. Central nervous system involvement in
rheumatoid disease. Neurology 1967; 17:1099-1105.

[135] Ramos, M., Mandybur, T. I. Cerebral vasculitis in rheumatoid arthritis. Arch. Neurol.
1975; 32:271-275.

[136] Steiner, J. W., Gelbloom, A. J. Intracranial manifestations in two cases of systemic
rheumatoid disease. Arthritis Rheum. 1959; 2:537-545.

[137] Puéchal, X., Said, G., Hilliquin, P., et al. Peripheral neuropathy with necrotizing
vasculitis in rheumatoid arthritis. Arthritis Rheum. 1995; 38:1618-1629.

[138] Pirani, C. L., Bennett, G. A. Rheumatoid arthritis; a report of three cases progressing
from childhood and emphasizing certain systemic manifestations. Bull. Hosp. Joint Dis.
1951; 12:335-367.

[139] Kemper, J. W., Baggenstoss, A. H., Slocumb, C. H. The relationship of therapy with
cortisone to the incidence of vascular lesions in rheumatoid arthritis. Ann. Intern. Med.
1957; 46:831-851.

[140] Sokoloff, L., Bunim, J. J. Vascular lesions in rheumatoid arthritis. J. Chronic Dis. 1957;
5:668-687.

[141] Johnson, R. L., Smyth, C. J., Holt, G. W., et al. Steroid therapy and vascular lesions in
rheumatoid arthritis. Arthritis Rheum. 1959; 2:224-249.

[142] Watson, P., Fekete, J., Deck, J. Central nervous system vasculitis in rheumatoid
arthritis. Can. J. Neurol. Sci. 1977; 4:269-272.

[143] Puéchal, X., Gottenberg, J. E., Berthelot, J. M., et al. Rituximab therapy for systemic
vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and
Rituximab Registry. Arthritis Care and Research 2012; 64:331-339.

[144] Bartels, C. M., Bridges, A. J. Rheumatoid vasculitis: Vanishing menace or target for
new treatments? Curr. Rheumatol. Rep. 2010; 12:414-419.

[145] Bartolucci, P., Ramanoelina, J., Cohen, P., et al. Efficacy of the anti-TNF? antibody
infliximab against refractory systemic vasculitides: an open pilot stud on 10 patients.
Rheumatology 2002; 41:1126-1132.

[146] Puéchal, X., Miceli-Richard, C., Mejjad, O., et al. Anti-tumor necrosis factor treatment
in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann.
Rheum. Dis. 2008; 67:880-884.

[147] Adams, R., Kubik, C., Bonner, F. The clinical and pathological aspects of influenza
meningitis. Arch. Pediatr. 1948; 65: 354-376; 408-441.

[148] Smith, J. F., Landing, B. H. Mechanisms of brain damage in H. influenza meningitis. J.
Neurosurg. 1960; 19: 248-265.

[149] Smith, H. V., Daniel, P. Some clinical and pathological aspects of tuberculosis of the
central nervous system. Tuberculosis 1947; 28: 64-80.

[150] Greitz, T. Angiography in tuberculous meningitis. Acta Radiology 1964; 2:369-377.
[151] Lehrer, H. The angiographic triad in tuberculous meningitis. A radiographic and

clinicopathologic correlation. Radiology 1966; 87:829-835.
[152] Kopsachilis, N., Brar, M., Marinescu, A., et al. Central nervous system tuberculosis

presenting as branch retinal vein occlusion. Clin. Exp. Optom. 2013; 96: 121-123.
[153] Feng, W., Caplan, M., Matheus, M., et al. Meningovascular syphilis with fatal

vertebrobasilar occlusion. Am. J. Med. Sci. 2009; 338: 169-171.
[154] Rabinov, K. R. Angiographic findings in a case of brain syphilis. Radiology 1963; 80:

622-624.

Complimentary Contributor Copy